CCEA approves foreign investments worth Rs 2,022 crore in Glenmark Pharmaceuticals

08 Apr 2015 Evaluate

The Cabinet Committee on Economic Affairs (CCEA) has approved foreign investments in Glenmark Pharmaceuticals. The company has increased the foreign investment limit by FIIs from 35.07% to 49%. This will result in an inflow of about Rs 2,022 crore.

Apart from manufacturing pharmaceuticals, the company is also engaged in Research and Development activities in drugs. Glenmark Pharmaceuticals is a $1 billion Indian pharmaceutical company, with a global presence with manufacturing facilities in India, Europe and South America.


Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×